Bristol Myers Squibb has appointed Dr. Chris Shibutani, a physician and former senior biotech analyst at Goldman Sachs, as EVP and chief strategy officer. Shibutani's role will encompass long-term strategy, external partnerships, and institutional collaborations. His combined clinical and financial expertise places him among a growing trend of pharma firms recruiting leaders with dual scientific and investment backgrounds to guide strategic decision-making.